Country Medical Manager – CVM (Pipeline & Prelaunch Focus)

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

This Opportunity

Strategic scientific lead responsible for driving early medical readiness, scientific narratives, and cross-functional launch preparation for pipeline assets in MASH and Obesity/T2DM.

Core Competencies & Strategic Responsibilities

Pipeline Strategy & Multi-Asset Management: Formulate pre-launch medical strategies and manage multi-indication pipelines simultaneously. Provide local medical input into clinical trial protocols, feasibility, and trial site selection in partnership with R&D and Clinical Operations.

Strategic Insight Generation & asset positioning: Analyze field MSM insights and convert into concrete medical strategies, generating viable medical tactics suitable nationwide and create a differentiated medical value proposition.

Market Agility & Competitive Intelligence: Analyze the fast-evolving CVRM landscape (e.g., GLP-1/GIP/glucagon co-agonists, novel MASH targets) to pivot medical strategies rapidly within China's dynamic market.

Cross-Functional & Global Collaboration: Work seamlessly in a matrix environment—aligning field MSM insight loops, guiding Commercial/Marketing strategy, providing scientific value narratives for Market Access (NRDL), and representing China needs to Global Medical teams.

Academic Rigor & AI Innovation: Quickly master complex, overlapping metabolic pathways. Leverage AI tools for accelerated literature mining, scientific content generation, competitive monitoring, and insight synthesis.

Evidence Generation & RWE Strategy : Identify local evidence gaps and design China-specific evidence generation plans, including Investigator-Initiated Studies (IIS) and Real-World Evidence (RWE) to support clinical guidelines and reimbursement strategy.

Cross-Specialty KOL Engagement: Map and engage key external experts across intersecting therapeutic silos (Endocrinologists, Hepatologists, and Cardiologists).

Candidate Qualifications & Baseline Requirements

Education: MD, PhD, or Master's in Clinical Medicine or Pharmacology (Life Sciences) (MD/PhD strongly preferred, background in Endocrinology, Hepatology, or Cardiovascular medicine preferred).

Experience: 3+ years in MNC Medical Affairs (in related therapeutic areas preferred), Multi-product pre-launch experience is a major plus.

Business Acumen: Demonstrated ability to connect scientific strategy with commercial realities and launch timing.

Languages : Native/Fluent Mandarin and high proficiency in written/spoken English for global matrix reporting.

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.

Let’s build a healthier future, together.

Roche is an Equal Opportunity Employer.